Read More Pharma Industry News Clene Nanomedicine raises $42.5m for developing nanocatalysts for neurodegenerative diseases Clene Nanomedicine, which is engaged in developing nanocatalysts for the treatment of bioenergetic failure associated with neurodegenerative diseases,… bypharmanewsdailyAugust 30, 2020